Bliss GVS Pharma Limited announced earnings results for the third quarter ended December 31, 2020. For the third quarter, the company announced total revenue was INR 1,681.766 million compared to INR 1,533.654 million a year ago. Net income was INR 255.506 million compared to INR 237.458 million a year ago. Basic earnings per share from continuing operations was INR 2.48 compared to INR 2.3 a year ago. Diluted earnings per share from continuing operations was INR 2.43 compared to INR 2.3 a year ago. For the nine months, total revenue was INR 4,590.497 million compared to INR 5,900.283 million a year ago. Net income was INR 622.488 million compared to INR 885.178 million a year ago. Basic earnings per share from continuing operations was INR 6.03 compared to INR 8.58 a year ago. Diluted earnings per share from continuing operations was INR 5.91 compared to INR 8.58 a year ago.